196 related articles for article (PubMed ID: 31145316)
1. Safety of aripiprazole for tics in children and adolescents: A systematic review and meta-analysis.
Yang C; Yi Q; Zhang L; Cui H; Mao J
Medicine (Baltimore); 2019 May; 98(22):e15816. PubMed ID: 31145316
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole for the treatment of tic disorders in children: a systematic review and meta-analysis.
Yang CS; Huang H; Zhang LL; Zhu CR; Guo Q
BMC Psychiatry; 2015 Jul; 15():179. PubMed ID: 26220447
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of aripiprazole for tic disorders in children and adolescents: A systematic review and meta-analysis.
Wang S; Wei YZ; Yang JH; Zhou YM; Cheng YH; Yang C; Zheng Y
Psychiatry Res; 2017 Aug; 254():24-32. PubMed ID: 28441584
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole alone or in combination for acute mania.
Brown R; Taylor MJ; Geddes J
Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
[TBL] [Abstract][Full Text] [Related]
5. Aripiprazole for Tourette's syndrome: a systematic review and meta-analysis.
Zheng W; Li XB; Xiang YQ; Zhong BL; Chiu HF; Ungvari GS; Ng CH; Lok GK; Xiang YT
Hum Psychopharmacol; 2016 Jan; 31(1):11-8. PubMed ID: 26310194
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation).
Ostinelli EG; Jajawi S; Spyridi S; Sayal K; Jayaram MB
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD008074. PubMed ID: 29308601
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the Efficacy and Tolerability of Topiramate for Tic Disorders: A Meta-Analysis.
Yu L; Yan J; Wen F; Wang F; Liu J; Cui Y; Li Y
J Child Adolesc Psychopharmacol; 2020 Jun; 30(5):316-325. PubMed ID: 32191124
[No Abstract] [Full Text] [Related]
8. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis.
Bernagie C; Danckaerts M; Wampers M; De Hert M
CNS Drugs; 2016 Sep; 30(9):807-18. PubMed ID: 27395403
[TBL] [Abstract][Full Text] [Related]
10. Comparative Efficacy and Safety of Antipsychotic Drugs for Tic Disorders: A Systematic Review and Bayesian Network Meta-Analysis.
Yang C; Hao Z; Zhang LL; Zhu CR; Zhu P; Guo Q
Pharmacopsychiatry; 2019 Jan; 52(1):7-15. PubMed ID: 29506305
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Iwata N
Psychopharmacology (Berl); 2020 May; 237(5):1459-1470. PubMed ID: 32002559
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of aripiprazole in the treatment of childhood tic disorders: a Meta analysis].
Fang Q; Chen L; Chen QB; Yang F
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jul; 17(7):715-20. PubMed ID: 26182278
[TBL] [Abstract][Full Text] [Related]
13. Haloperidol alone or in combination for acute mania.
Cipriani A; Rendell JM; Geddes JR
Cochrane Database Syst Rev; 2006 Jul; (3):CD004362. PubMed ID: 16856043
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole for autism spectrum disorders (ASD).
Ching H; Pringsheim T
Cochrane Database Syst Rev; 2012 May; (5):CD009043. PubMed ID: 22592735
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole versus other atypical antipsychotics for schizophrenia.
Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
[TBL] [Abstract][Full Text] [Related]
16. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Otasowie J; Castells X; Ehimare UP; Smith CH
Cochrane Database Syst Rev; 2014 Sep; (9):CD006997. PubMed ID: 25238582
[TBL] [Abstract][Full Text] [Related]
17. Systemic review of aripiprazole for the treatment of children and adolescents with tic disorders.
Ghanizadeh A
Neurosciences (Riyadh); 2012 Jul; 17(3):200-4. PubMed ID: 22772923
[TBL] [Abstract][Full Text] [Related]
18. Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis.
Almandil NB; Liu Y; Murray ML; Besag FM; Aitchison KJ; Wong IC
Paediatr Drugs; 2013 Apr; 15(2):139-50. PubMed ID: 23519708
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change.
Mankoski R; Stockton G; Manos G; Marler S; McQuade R; Forbes RA; Marcus R
J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):572-6. PubMed ID: 24138011
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of efficacy and safety of aripiprazole in adult and pediatric bipolar disorder in randomized controlled trials and observational studies.
Meduri M; Gregoraci G; Baglivo V; Balestrieri M; Isola M; Brambilla P
J Affect Disord; 2016 Feb; 191():187-208. PubMed ID: 26674213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
